SS
MIRM icon

SBI Securities’s Mirum Pharmaceuticals MIRM Stock Holding History

SBI Securities’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20
Closed -$1.85K – 4154
2026
Q1 		$1.85K Buy
+20
New +$1.88K ﹤0.01% 2448
2025
Q4 		– Sell
-150
Closed -$11K – 4146
2025
Q3 		$11K Buy
150
+121
+417% +$7.69K ﹤0.01% 1731
2025
Q2 		$1.48K Buy
+29
New +$1.29K ﹤0.01% 2518

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's MIRM Position: Q2 2026 in Review

SBI Securities sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 20 shares — an estimated $1.85K sold.

SBI Securities first reported a position in MIRM in Q2 2025 and held it in 3 quarters. The position peaked at $11K in Q3 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • SBI Securities reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • SBI Securities sold 20 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.85K.
  • SBI Securities first reported a position in Mirum Pharmaceuticals in Q2 2025 and held it in 3 quarters.
  • SBI Securities's Mirum Pharmaceuticals position peaked at $11K in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.